In summary, our findings highlight that USP21-mediated post-translational regulation of HSP90 and ENO1 is important in aerobic glycolysis and CCA tumor progression and provide an option for cancer therapy targeting glucose metabolism. The gene discussed is USP21; the disease is cancer.